Rudoy R C, Nelson J D, Haltalin K C
Antimicrob Agents Chemother. 1974 May;5(5):439-43. doi: 10.1128/AAC.5.5.439.
Trimethoprim and sulfamethoxazole were tested alone and in combination against 227 recently isolated Shigella strains. Variations in medium constituents and inoculum size were used to determine the optimal testing conditions. The plate dilution method with addition of 5% lysed horse blood to the susceptibility test medium and an inoculum size of 10(2) organisms was found to provide satisfactory results. All 227 strains were inhibited by low concentrations of trimethoprim, and all were susceptible to the combination of 0.06 mug of trimethoprim per ml and 1.25 mug of sulfamethoxazole per ml. Sixteen percent of these strains were resistant to ampicillin, 33% to tetracycline, 15% to chloramphenicol, and 27% to cephalothin. Based on these in vitro observations, trimethoprim and sulfamethoxazole appear worth evaluating for treatment of shigellosis due to multiply antibiotic-resistant strains.
对甲氧苄啶和磺胺甲恶唑单独及联合应用于227株近期分离出的志贺氏菌菌株进行了测试。通过改变培养基成分和接种量来确定最佳测试条件。发现在药敏试验培养基中添加5%裂解马血并接种量为10(2)个生物体的平板稀释法能提供满意结果。所有227株菌株均被低浓度的对甲氧苄啶抑制,并且对每毫升含0.06微克对甲氧苄啶和1.25微克磺胺甲恶唑的联合制剂均敏感。这些菌株中16%对氨苄西林耐药,33%对四环素耐药,15%对氯霉素耐药,27%对头孢菌素耐药。基于这些体外观察结果,对甲氧苄啶和磺胺甲恶唑似乎值得评估用于治疗多重耐药菌株所致的志贺氏菌病。